Main Uses and Benefits of Ревит

The primary therapeutic use of Ревит involves the management of clinical manifestations associated with hypovitaminosis, specifically deficiencies in Vitamins A, B₁, B₂, and C. Its application is considered relevant for supportive care to address nutritional shortfalls and manage resulting symptomatic patterns.

This preparation is commonly used across conditions presenting with symptom clusters related to delayed wound healing, gingival fragility, and dryness of mucous membranes (A, C); as well as persistent fatigue, generalized weakness, and specific nerve issues (neuritis) (B₁). This approach is relevant for easing symptoms that create noticeable physiological strain and is frequently applied during periods of convalescence after illness, seasonal changes, or when absorption is affected.

These nutrients are essential for a variety of critical body functions, which aligns with the core therapeutic domains of supportive care in deficiency states. The combination contributes to easing the overall symptom load and supports patients during difficult episodes by addressing the symptoms related to nutritional shortfalls.

---

Quick Fact: Relief for Deficiency Symptoms

Symptom Domain	Key Benefit Provided
Tissue Integrity Issues	Contributes to the normal maintenance of epithelial structure and aids in tissue repair.
Neurological Fatigue	Supports functions related to energy production and helps manage symptoms of increased neurological or muscular activity.
Deficiency Prophylaxis	Assists with maintaining a sense of stability during periods of increased nutrient demand.

Regulatory References

1. NIH MedlinePlus overview of vitamins

Eligibility Map: Who can and cannot use Ревит

This medicine is a multi-vitamin formulation (typically containing vitamins A, B1, B2, and C) and its use is strictly governed by the official regulatory documents, which define the eligible population and those for whom use is prohibited or restricted.

---

Eligibility Scope

• Populations for whom use is contraindicated: Patients with known hypersensitivity or allergy to the active substances or any excipients in the formulation. Formal contraindications include conditions related to excessive vitamin levels, specifically hypervitaminosis A. The label also prohibits use in individuals with fructose intolerance, glucose-galactose malabsorption syndrome, and documented disorders of iron or copper metabolism.
• Condition-specific eligibility rules: Use is restricted or contraindicated in those with thrombosis or a tendency towards it, thrombophlebitis, and diabetes mellitus. Patients with chronic glomerulonephritis, severe kidney disease, and a history of sarcoidosis must not use the medicine, or require special consideration due to risk of accumulation or adverse effects.
• Age-related eligibility rules: Specific age limits are defined in the regulatory sources; for example, use may be limited to adults and children above a certain age threshold.

---

Eligibility-Related Restrictions

• Use Restriction: The medicine is generally not recommended in high doses for patients with urolithiasis (kidney stones), particularly at daily doses exceeding a specific threshold (1 g).
• Pregnancy and Lactation: Eligibility status for use during pregnancy and breastfeeding must be determined by a healthcare professional, weighing potential benefits against risks, as vitamin levels require careful management during these periods.

Interactions with other medicines and products

The interaction profile for Ревит components is derived from official regulatory documents, primarily focusing on pharmacodynamic and pharmacokinetic effects that alter systemic exposure or increase toxicity risk.

Documented Interaction Restrictions

Restriction Type	Interacting Agent	Official Constraint
Formal Contraindication	Tetracyclines / Other Systemic Retinoids	Prohibited co-administration due to the risk of pseudotumor cerebri or Hypervitaminosis A (Vitamin A component).
Timing Separation	Aluminum-Containing Antacids	Administration must be separated to mitigate the risk of increased aluminum absorption (Vitamin C component).
Absorption Interference	Cholestyramine / Mineral Oil	Requires separate dosing times to ensure adequate gastrointestinal absorption of the fat-soluble Retinol (Vitamin A) component.

Other Clinically Relevant Interactions

High intake of the Retinol (Vitamin A) component may potentiate the effects of oral anticoagulants (e.g., Warfarin), increasing the official risk of hemorrhage. The Thiamine (Vitamin B₁) component is subject to interference by alcohol consumption, which is documented to inhibit its absorption and accelerate its metabolic clearance. Furthermore, the use of oral contraceptives may increase the plasma concentration of Retinol. The potential for Ascorbic Acid (Vitamin C) to increase aluminum absorption is a documented risk of specific concern for patients with impaired renal function.

The physiological effects of Ревит arise from the essential, non-pharmacological roles of its four vitamin components as cofactors and nuclear receptor ligands, which are required for core metabolic and structural pathway function.

️ Facilitation of Core Cellular Bioenergetics

The B-vitamins, Thiamine (B1) and Riboflavin (B2), function as obligate cofactors (coenzymes) for critical enzyme complexes, including those in the Krebs Cycle and the Electron Transport Chain (ETC). This molecular action enables the body's efficient breakdown of carbohydrates and fats, maintaining the potential for sustained ATP production required by high-demand organ systems (e.g., CNS, muscle).

️ Regulation of Structural Integrity and Connective Tissue Synthesis

Ascorbic Acid (Vitamin C) acts as a necessary reducing agent for hydroxylase enzymes that enable the post-translational modification and subsequent proper cross-linking of collagen fibers. Simultaneously, Retinol (Vitamin A) modulates gene transcription required for the maturation and functional state of epithelial barriers (skin and mucosa). This combined mechanism contributes to the structural assembly and metabolism of connective tissues and protective linings.

️ Modulation of Cell Differentiation and Redox Balance

Retinol (Vitamin A) binds to Nuclear Receptors (RARs/RXRs) to regulate gene expression central to cell differentiation and immune function, providing a foundational regulatory mechanism. This is complemented by the antioxidant activity of Vitamin C, which directly scavenges free radicals, and Riboflavin, which supports key cellular redox enzymes. Together, these actions support the molecular mechanisms of cellular protection and contribute to cellular homeostatic regulation.

The administration of Ревит is characterized by the use of the dragee (coated tablet) through the oral route. The standard dosing regimen for adults is structured around a once-daily intake of 1 to 2 dragees. For specific management protocols, the dose may be increased up to 3 dragees per day for limited, acute periods.

A critical instruction specifies that the dragee must be taken after a meal. This timing is a key administration constraint, ensuring the optimal context for ingestion and aiding in the absorption of the fat-soluble component, Retinol (Vitamin A). The dragee must be swallowed whole with water and should not be chewed or crushed, a procedural step common to coated oral solid dosage forms.

The duration of use for this multivitamin complex is organized into defined treatment courses lasting approximately 20 to 30 days. This regimen of intermittent, cyclical use frames its role as a periodic supplement to address nutritional shortfalls. The medicine is also indicated for use in children from a specific minimum age, following similar time-based usage patterns. These guidelines define a consistent, time-limited approach to supplementation.

Research Evidence / Overview of Studies for Ревит

This overview describes the types of research and study outcomes that have been evaluated for multivitamin preparations containing Retinol (Vitamin A), Thiamine ( B1), Riboflavin ( B2), and Ascorbic Acid (Vitamin C). The findings reported below reflect what has been observed in study populations and should not be taken as individual predictions or clinical recommendations.

---

1. Evidence for Correcting Documented Vitamin Deficiencies

Research exploring the effects of this multivitamin combination has been used in research contexts involving clear instances of nutrient shortfall, or hypovitaminosis. The focus of these studies is on how providing the vitamins was observed in relation to measurable physiological changes.

Researchers primarily used short-term controlled human studies and randomized controlled trials (RCTs). These studies included populations with known or induced biochemical shortages of one or more specific vitamins. The study outcomes examined included the change in blood concentrations of the vitamins and the monitoring of certain enzyme activity levels. Trials consistently reported patterns where providing the specified nutrients was associated with a measured change in the initial biochemical deficit.

---

2. Evidence for General Nutritional Support and Well-being

Studies have explored whether supplementation during times of stress, illness, or perceived high demand was associated with overall physiological function. This research includes systematic reviews and long-term observational cohort studies.

Research examined functional outcomes, such as measurements related to physical performance or measures of recovery during convalescence. Findings describe patterns observed in these studies where multivitamin use was associated with observed variations in the proportion of participants having suboptimal levels of certain micronutrients. Findings were mixed in large-scale randomized trials regarding whether multivitamin complexes influence the long-term risk of major chronic diseases.

---

3. Gaps and Areas of Scientific Uncertainty

Research provides context, but limitations remain. The evidence quality varies across studies, with observational data being prone to the challenge of isolating the supplement's effect from other healthy lifestyle behaviors. Furthermore, the results apply only to the populations studied, and there is limited information for long-term outcomes regarding the complex's relationship to outcomes related to chronic disease risk in generally healthy adults. Finally, comparative evidence is lacking for the specific, four-component blend against other multivitamin formulations.

Common questions about Ревит (FAQ)

---

Q: Can taking Ревит cause any issues with my stomach or digestion?

Regulatory documents state that potential gastrointestinal reactions are possible side effects when taking this medication. These reactions can include general abdominal discomfort, nausea, vomiting, and dyspepsia (indigestion). Should a patient experience severe or persistent symptoms, seeking professional health guidance is the appropriate step.

Q: Can Ревит affect my blood test results?

According to official product information, the ascorbic acid component (Vitamin C) may interfere with the results of certain laboratory tests. This interference can specifically affect tests for substances such as blood glucose, bilirubin, and specific enzyme activity. Disclosing all medications to the testing laboratory or healthcare provider is generally understood to be a necessary standard procedure.

Q: Can Ревит cause any skin reactions or mild itching?

Officially documented adverse reactions include skin responses that are classified as manifestations of hypersensitivity. These can include a rash, redness, urticaria (hives), and pruritus (itching). These reactions are described in the official safety information for the product.

Q: Is it okay to take Ревит for longer than one month?

The official usage pattern is structured around defined treatment courses, typically lasting 30 to 60 days. Regulatory documents indicate that the course of use may be repeated after a required break, usually lasting one to three months, as determined through professional health assessment.

Q: Can Ревит be taken without having a confirmed vitamin deficiency?

The official purpose of the medicine is twofold: the management of known vitamin deficiency (hypovitaminosis) and its use as a prophylactic (preventative) agent. Therefore, official indications allow for its use in conditions associated with an increased requirement for vitamins, even before a confirmed deficiency.

Q: Does Ревит affect energy levels or cause any trouble sleeping?

Official regulatory notes indicate that the medication does not typically affect the ability to manage transport or machinery, suggesting no major acute central nervous system effects. However, drowsiness has been noted as a potential symptom in cases where the recommended dosage is exceeded.

Q: What happens if I forget to take a dose of Ревит?

The official instructions do not contain a specific, defined procedure to follow if a dose of the medicine is forgotten. It is noted in the regulatory documents that patients should strictly avoid exceeding the prescribed daily dosage, as this is an important safety measure.

Q: Is the vitamin content in Ревит sufficient for daily recommended intake?

The general purpose of this preparation, according to official indications, is the prevention and management of hypovitaminosis, which means a shortfall in vitamins. The content is formulated to address these prophylactic and management goals when the medicine is taken as described in the official instructions.

Q: Why is the official source information sometimes different from what I see on forums?

Official product information is provided by government drug regulatory agencies based on verifiable data and the specific, approved formulation. In contrast, information found on public forums comes from personal accounts and opinions that are not subject to the same strict regulatory review and verification process.

Q: Can children accidentally overdose on the chewable form of Ревит?

Official safety warnings caution against exceeding the recommended daily dose for all users of the medication. Furthermore, regulatory documents state that if high doses are accidentally ingested, official documents indicate that immediate medical attention is required. Safety constraints emphasize keeping the medication out of the sight and reach of children.

Q: Can I use it for boosting energy?

Official documents indicate the medicine's general purpose is to provide nutritional support and address conditions where there is an increased need for vitamins. This includes situations of increased physical or mental activity, which is the underlying factual basis for the perception of needing a physiological boost.

Q: Is it true that the vitamins in Ревит are beneficial for eyesight?

The composition of this medication includes Retinol (Vitamin A), which is recognized in official descriptions as an essential nutrient. Retinol plays a role in supporting the functions of epithelial barriers and the process of cell differentiation, which are fundamental physiological processes.

Q: Why is it common to take Ревит during the spring and winter?

Official indications state that the preparation is to be used as a prophylactic agent during periods associated with an increased requirement for vitamins. This general purpose aligns with the idea of providing supportive nutrients during times when dietary intake may be lacking or physiological stress is elevated.

How to Store and Dispose of Ревит?

The official storage and disposal guidelines for Ревит (a multivitamin dragee) must be followed to maintain the potency and stability of the vitamins until the expiration date.

Storage Requirements

Condition	Requirement
Temperature	Store below 25 C (77 F). Do not freeze.
Protection	Keep tightly closed in the original container, protected from both light and moisture.
Child Safety	Store the medicine out of the sight and reach of children.

Storage under these required conditions ensures product stability up to the labeled expiration date. The medicine must not be used after this date.

Disposal Instructions

Unused or expired Ревит must be disposed of according to local pharmaceutical regulations, which may include drug take-back programs. The product should not be flushed down a toilet or poured into a drain to prevent environmental contamination, as advised by regulatory authorities.